for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

Antibody therapy developer AbCellera looks to raise up to $200 mln in IPO

Nov 20 (Reuters) - Canadian biotech company AbCellera Biologics Inc on Friday filed for an initial public offering of up to $200 million, according to a regulatory filing. (Reporting by Ayanti Bera in Bengaluru;Editing by Arun Koyyur)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up